Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oralieve moisturising mouth spray
21210000022
|
Oralieve moisturising mouth spray | Dry Mouth Products | Appliances | 9,271 |
|
Atrauman dressing 5cm x 5cm
20030100066
|
Atrauman dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | 9,266 |
|
Topiramate 25mg capsules
040801050AAAVAV
|
Topiramate | Topiramate | Central Nervous System | 9,259 |
|
Lipitor 40mg tablets
0212000B0BBACAC
|
Lipitor | Atorvastatin | Cardiovascular System | 9,255 |
|
YES VM vaginal moisturiser pre-filled applicators
21230000118
|
YES VM vaginal moisturiser pre-filled applicators | Vaginal Moisturisers | Appliances | 9,243 |
|
Tolterodine 2mg modified-release capsules
0704020N0AAAIAI
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 9,241 |
|
Reletrans 20micrograms/hour transdermal patches
0407020B0BKADAJ
|
Reletrans | Buprenorphine | Central Nervous System | 9,232 |
|
Fluticasone propionate 250microg/Salmeterol 50microg/dose
0302000N0AAAYAY
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 9,209 |
|
Omeprazole 40mg dispersible gastro-resistant tablets
0103050P0AAAPAP
|
Omeprazole | Omeprazole | Gastro-Intestinal System | 9,203 |
|
Clonazepam 1mg tablets
0408010F0AADEDE
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | 9,201 |
|
AeroChamber Plus Flow-Vu Anti-Static with medium mask child 1-5 years
21010230168
|
AeroChamber Plus Flow-Vu Anti-Static with medium mask child 1-5 years | Other Appliances | Appliances | 9,191 |
|
GlucoRx Safety lancets 1.6mm/30gauge
21010900853
|
GlucoRx Safety lancets 1.6mm/30gauge | Other Appliances | Appliances | 9,173 |
|
Betamethasone dipropionate 0.05% / Salicylic acid 3% oint
1304000D0AABBBB
|
Betamethasone esters | Betamethasone esters | Skin | 9,168 |
|
Tramadol 37.5mg / Paracetamol 325mg tablets
040702040AAAUAU
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | 9,166 |
|
Lithium carbonate 400mg modified-release tablets
0402030K0AAAFAF
|
Lithium carbonate | Lithium carbonate | Central Nervous System | 9,159 |
|
Clinitas Multi 0.2% eye drops preservative free
21300000907
|
Clinitas Multi 0.2% eye drops preservative free | Eye Products | Appliances | 9,140 |
|
Codeine 15mg/5ml linctus
0309010C0AAAAAA
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | 9,126 |
|
Lidocaine 100mg/5ml (2%) solution for injection ampoules
1502010J0AACBCB
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 9,091 |
|
Umeclidinium brom 65microg/Vilanterol 22microg/dose dry pdr
0301040W0AAAAAA
|
Umeclidinium bromide/vilanterol | Umeclidinium bromide/vilanterol | Respiratory System | 9,091 |
|
Mercilon 150microgram/20microgram tablets
0703010E0BCAAAB
|
Mercilon | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 9,066 |
|
Dantrolene 25mg capsules
1002020J0AAAAAA
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | 9,065 |
|
Levothyroxine sodium 50micrograms/5ml soln sugar free
0602010V0AAGAGA
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 9,051 |
|
Calcium and Ergocalciferol tablets
0906040N0AAA1A1
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | 9,049 |
|
Systane eye drops 0.8ml unit dose preservative free
21300000109
|
Systane eye drops 0.8ml unit dose preservative free | Eye Products | Appliances | 9,039 |
|
Pentasa 1g modified-release granules sachets
0105010B0BCAEAN
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 9,037 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.